• Explore /
  • Poster
  • / Phase II study of atezolizumab and bevacizumab combination therapy for patients with advanced hepatocellular carcinoma who previously received systemic treatment.

Phase II study of atezolizumab and bevacizumab combination therapy for patients with advanced hepatocellular carcinoma who previously received systemic treatment.

Abstract Poster

Authors

null

Takeshi Terashima

Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan

Takeshi Terashima , Tatsuya Yamashita , Makoto Yamamoto , Masahiro Yanagi , Hidetoshi Nakagawa , Akihiro Seki , Kouki Nio , Kuniaki Arai , Tadashi Toyama , Taro Yamashita

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

jRCT1041200068

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 495)

DOI

10.1200/JCO.2024.42.3_suppl.495

Abstract #

495

Poster Bd #

D2

Abstract Disclosures

Similar Posters

First Author: Joshua E. Reuss

First Author: Leijuan Gan

First Author: Jaekyung Cheon

First Author: Wen Wee Ma